Ignite Creation Date:
2025-12-25 @ 4:47 AM
Ignite Modification Date:
2026-01-27 @ 12:20 AM
Study NCT ID:
NCT00402818
Status:
TERMINATED
Last Update Posted:
2014-08-29
First Post:
2006-11-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
RESTORE: Raptiva® (Efalizumab) Evaluation of Safety and Treatment Optimization
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
26768
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None